Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Hallek

Showing results (1-10 of 601) with videos related to

Pageof 61
Sort By:
Der Internist|June 9, 2021
[Cellular immunotherapies]Michael Hallek
Best Practice & Research. Clinical Haematology|July 13, 2010
Therapy of chronic lymphocytic leukaemiaMichael Hallek
Nature Clinical Practice. Oncology|August 4, 2005
Chemoimmunotherapy--towards real progress in the treatment of chronic lymphocytic leukemiaMichael Hallek
Blood|June 2, 2012
FCA: forget chemoimmunotherapy with alemtuzumab?Michael Hallek
Hematology. American Society of Hematology. Education Program|November 24, 2005
Chronic lymphocytic leukemia (CLL): first-line treatmentMichael Hallek,
Hematology. American Society of Hematology. Education Program|December 10, 2013
Signaling the end of chronic lymphocytic leukemia: new frontline treatment strategiesMichael Hallek
Deutsche Medizinische Wochenschrift (1946)|April 1, 2015
[Clinical trials in Germany: the time to reduce bureaucracy has come!]Michael Hallek
Hematology. American Society of Hematology. Education Program|December 17, 2009
State-of-the-art treatment of chronic lymphocytic leukemiaMichael Hallek
Hematology. American Society of Hematology. Education Program|December 4, 2018
On the architecture of translational research designed to control chronic lymphocytic leukemiaMichael Hallek
Onkologie|December 5, 2012
Professor Hans-Joachim Schmoll - 10 years editor-in-chief of OnkologieMichael Hallek
Pageof 61

Showing results (1-10 of 601) with videos related to

Sort By:
Pageof 61
Der Internist|June 9, 2021
[Cellular immunotherapies]Michael Hallek
Best Practice & Research. Clinical Haematology|July 13, 2010
Therapy of chronic lymphocytic leukaemiaMichael Hallek
Nature Clinical Practice. Oncology|August 4, 2005
Chemoimmunotherapy--towards real progress in the treatment of chronic lymphocytic leukemiaMichael Hallek
Blood|June 2, 2012
FCA: forget chemoimmunotherapy with alemtuzumab?Michael Hallek
Hematology. American Society of Hematology. Education Program|November 24, 2005
Chronic lymphocytic leukemia (CLL): first-line treatmentMichael Hallek,
Hematology. American Society of Hematology. Education Program|December 10, 2013
Signaling the end of chronic lymphocytic leukemia: new frontline treatment strategiesMichael Hallek
Deutsche Medizinische Wochenschrift (1946)|April 1, 2015
[Clinical trials in Germany: the time to reduce bureaucracy has come!]Michael Hallek
Hematology. American Society of Hematology. Education Program|December 17, 2009
State-of-the-art treatment of chronic lymphocytic leukemiaMichael Hallek
Hematology. American Society of Hematology. Education Program|December 4, 2018
On the architecture of translational research designed to control chronic lymphocytic leukemiaMichael Hallek
Onkologie|December 5, 2012
Professor Hans-Joachim Schmoll - 10 years editor-in-chief of OnkologieMichael Hallek
Pageof 61